Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.160 GeneticVariation disease GWASCAT Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. 31118516 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.160 Biomarker disease BEFREE CDC123/CAMK1D and CDKN2A/2B are associated with increased risk of type 2 diabetes and may affect pancreatic beta cell function. 28079868 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.160 GeneticVariation disease BEFREE Thus, we aimed to investigate the contribution of rs1111875 (HHEX), rs1800961 (HNF4α), rs5219 (KCNJ11), rs1801282 (PPARγ), rs10811661 (CDKN2A/2B), rs13266634 (SLC30A8), rs12779790 (CDC123/CAMK1D), rs7903146 (TCF7L2), rs9282541 (ABCA1) and rs13342692 (SLC16A11) polymorphisms in the genetic background of Maya population to associate their susceptibility to develop T2D. 25839936 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.160 GeneticVariation disease BEFREE Genetic variants at CDC123/CAMK1D and SPRY2 are associated with susceptibility to type 2 diabetes in the Japanese population. 21909839 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.160 GeneticVariation disease GWASDB Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. 22158537 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.160 GeneticVariation disease BEFREE Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. 19833888 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.160 Biomarker disease BEFREE These findings suggest that CDC123/CAMKID could be a major risk factor for the development of T2D in Sikhs by affecting beta-cell function. 19247373 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.160 GeneticVariation disease BEFREE If replicated, our data suggest that type 2 diabetes at-risk alleles in the JAZF1, CDC123/CAMK1D, and TSPAN8 loci associate with various OGTT-based surrogate measures of insulin release, emphasizing the contribution of abnormal pancreatic beta-cell function in the pathogenesis of type 2 diabetes. 18567820 2008